Does Drugs That Prolong The Qt Interval Interact with Mannitol?
Drugs That Prolong The Qt Interval and Mannitol have a moderate drug interaction according to U.S. FDA drug labeling data. Electrolyte imbalances from mannitol may result in cardiac adverse reactions; monitor serum electrolytes. The mechanism involves qt-sensitive drugs affected by mannitol-induced electrolyte imbalances. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Mannitol Class
- Osmotic Diuretic
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Drugs That Prolong The Qt Interval and Mannitol occurs because qt-sensitive drugs affected by mannitol-induced electrolyte imbalances. Clinically, this means electrolyte imbalances from mannitol may result in cardiac adverse reactions; monitor serum electrolytes. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Drugs That Prolong The Qt Interval and your doctor is considering prescribing Mannitol (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider